Press release
September 25, 2026
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
Incyte Corp (INCY)
We couldn't retrieve the full text for this release. Read it on the company's site.